Nationally Notifiable Infectious Diseases and Conditions, United States: Weekly Tables

Weekly cases* of notifiable diseases, United States, U.S. Territories, and Non-U.S. Residents week ending November 2, 2024 (Week 44)
Reporting Area Gonorrhea §
Current weekPrevious 52 weeks Max †Cum YTD 2024 †Cum YTD 2023 †
U.S. Residents, excluding U.S. Territories 4,803 12,451 418,201 513,294
New England 174 450 11,401 14,168
Connecticut 1 96 1,899 3,534
Maine - 25 420 500
Massachusetts 134 230 7,486 8,267
New Hampshire - 23 404 491
Rhode Island 34 212 1,049 1,184
Vermont 5 8 143 192
Middle Atlantic 852 1,609 60,150 63,648
New Jersey 139 236 8,327 8,621
New York (excluding New York City) 250 309 10,419 11,570
New York City 177 744 26,405 27,537
Pennsylvania 286 408 14,999 15,920
East North Central 499 1,604 50,410 65,893
Illinois 24 577 12,651 21,341
Indiana 99 217 7,173 8,567
Michigan 54 319 10,611 13,017
Ohio 228 400 14,256 17,041
Wisconsin 94 170 5,719 5,927
West North Central 349 680 23,773 29,230
Iowa 47 85 2,712 3,240
Kansas 30 90 2,648 3,649
Minnesota 49 188 6,042 6,488
Missouri 212 260 8,669 10,854
Nebraska - 63 1,637 1,942
North Dakota - 25 630 1,002
South Dakota 11 56 1,435 2,055
South Atlantic 1,071 4,666 107,885 128,306
Delaware - 41 1,161 1,357
District of Columbia 27 139 4,633 4,887
Florida 533 2,716 35,397 39,730
Georgia - 635 19,407 26,406
Maryland - 301 8,298 10,663
North Carolina - 536 17,261 22,600
South Carolina 234 301 9,630 10,187
Virginia 272 328 11,529 11,675
West Virginia 5 27 569 801
East South Central 301 793 15,588 32,571
Alabama 158 247 7,521 10,105
Kentucky 101 223 4,083 4,991
Mississippi 42 293 3,984 6,213
Tennessee - 311 - 11,262
West South Central 236 1,696 57,961 68,596
Arkansas 64 141 4,120 5,152
Louisiana 68 281 8,786 11,420
Oklahoma 23 133 3,356 6,109
Texas 81 1,160 41,699 45,915
Mountain 280 823 26,313 31,030
Arizona 11 310 10,690 12,120
Colorado 100 227 5,324 6,421
Idaho 30 25 542 688
Montana 7 28 627 687
Nevada 82 155 4,897 5,499
New Mexico 10 73 2,326 3,090
Utah 40 70 1,787 2,314
Wyoming - 9 120 211
Pacific 1,041 1,926 64,720 79,852
Alaska 25 60 1,770 1,965
California 744 1,501 52,115 63,340
Hawaii - 39 - 1,575
Oregon 86 133 3,631 4,226
Washington 186 275 7,204 8,746
U.S. Territories - 33 37 1,004
American Samoa - 0 - -
Commonwealth of Northern Mariana Islands - 0 - -
Guam - 0 - -
Puerto Rico - 33 37 1,004
U.S. Virgin Islands - 0 - -
Non-U.S. Residents - 4 12 22
Total 4,803 12,456 418,250 514,320
  • U: Unavailable — The reporting jurisdiction was unable to send the data to CDC or CDC was unable to process the data.
  • -: No reported cases — The reporting jurisdiction did not submit any cases to CDC.
  • N: Not reportable — The disease or condition was not reportable by law, statute, or regulation in the reporting jurisdiction.
  • NN: Not nationally notifiable — This condition was not designated as being nationally notifiable.
  • NP: Nationally notifiable but not published.
  • NC: Not calculated — There is insufficient data available to support the calculation of this statistic.
  • Cum: Cumulative year-to-date counts.
  • * Case counts for reporting years 2023 and 2024 are provisional and subject to change. Cases are assigned to the reporting jurisdiction submitting the case to NNDSS, if the case's country of usual residence is the U.S., a U.S. territory, unknown, or null (i.e. country not reported); otherwise, the case is assigned to the 'Non-U.S. Residents' category. Country of usual residence is currently not reported by all jurisdictions or for all conditions. For further information on interpretation of these data, see https://www.cdc.gov/nndss/data-statistics/readers-guides/.
  • † Previous 52 week maximum and cumulative YTD are determined from periods of time when the condition was reportable in the jurisdiction (i.e., may be less than 52 weeks of data or incomplete YTD data).
  • § Beginning in January 2023, confirmed and probable cases only are being published to align with the approved CSTE position statement 22-ID-03, whereas in previous years, all case classification statuses were published. This change may cause a decrease in published case counts when compared to previous years.
Notes:
  • These are weekly cases of selected infectious national notifiable diseases, from the National Notifiable Diseases Surveillance System (NNDSS). NNDSS data reported by the 50 states, New York City, the District of Columbia, and the U.S. territories are collated and published weekly in alphabetical order by condition. Cases reported by state health departments to CDC for weekly publication are subject to ongoing revision of information and delayed reporting. Therefore, numbers listed in later weeks may reflect changes made to these counts as additional information becomes available. Case counts in the tables are presented as published each week. See also Guide to Interpreting Provisional and Finalized NNDSS Data.
  • Weekly tables since 1996 are available on CDC WONDER.
  • Weekly tables since 2014 are available on Data.CDC.gov.
  • Weekly tables for 1952–2017 published in the Morbidity and Mortality Weekly Reports (MMWR) are available at CDC Stacks MMWR, and weekly tables starting in 2018 are available at CDC Stacks NNDSS (once in CDC Stacks NNDSS select "Weekly Tables" in the "Genre" box at the left).
  • Notices, errata, and other notes are available in the Notice To Data Users page.
  • The list of national notifiable infectious diseases and conditions and their national surveillance case definitions are available at https://ndc.services.cdc.gov/. This list incorporates the Council of State and Territorial Epidemiologists (CSTE) position statements approved by CSTE for national surveillance.
Suggested Citation:
  • Centers for Disease Control and Prevention. National Notifiable Diseases Surveillance System, Weekly Tables of Infectious Disease Data. Atlanta, GA. Office of Public Health Data, Surveillance, and Technology. Available at: https://www.cdc.gov/nndss/data-statistics/index.html.
Acknowledgment:
  • CDC acknowledges the local, state, and territorial health departments that collected the data from a range of case ascertainment sources (e.g., health-care providers, hospitals, laboratories) and reported these data to CDC's National Notifiable Diseases Surveillance System.